In order to rationalize the strong inhibition of α-D-mannosidases by mannostatin A (1), a series of 1-amino-5-hydroxymethyl-2,3,4-cyclopentanetriols 2 were prepared as analogues of this lead compound and of the natural glycopyranoside substrates. High inhibitory activities, with Ki values below 1 μM, were found in all stereochemical series studied (D-gluco, D-manno, D-galacto, and D-GlcNAc configuration). Based on the promising results for the parent compounds 2, the β-D-galacto-configured series was chosen for optimization by varying the substitution at the nitrogen atom of the amino group. Highly potent N-benzyl-substituted derivatives with Ki values down to 0.0007 μM were obtained such as the bromo compound 3.
No takes yet. Share an insight, caveat, or question.
Kleban et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: